Novartis moves ahead with copies of Amgen drugs Economic Times Sandoz, which has 8-10 molecules in its biosimilar pipeline, has been trying to come up with a copy of Roche's antibody drug rituximab. It has already developed its own versions of growth hormone therapy somatropin and epoetin alfa to treat anaemia in ... Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term ... |
